BUZZ—IDEXX shares rise after raising full-year profit and revenue forecasts

November 2 - ** Veterinary diagnostic equipment manufacturer IDEXX Laboratories (IDXX.O) shares rose 5.5% in pre-market trading to $581.56

** The company raised its fiscal 2026 revenue forecast to the range of $4.74 billion to $4.76 billion, higher than the previous expectation of $4.7 billion to $4.74 billion

** Upgraded its fiscal 2026 earnings per share (EPS) forecast range from $14.69-$14.94 to $14.96-$15.16

** Strong performance mainly driven by an 11% revenue increase in its Companion Animal Group (CAG) segment, as well as robust same-store sales

** Third-quarter revenue (link) reached $1.21 billion, surpassing analyst expectations of $1.19 billion

** Of 15 brokerages, 9 rate the stock as “buy” or above, and 6 rate it as “hold”; the median target price is $707.50 — LSEG data

** As of the previous trading day's close, the stock had fallen 18.5% year-to-date

(To assist non-English speakers, Reuters provides its reports translated automatically into several other languages. As automated translation may be inaccurate or lack necessary context, Reuters does not guarantee the accuracy of automated translation texts and provides them solely for reader convenience. Reuters takes no responsibility for any damage or loss caused by the use of automated translation features.)